Rapid Micro Biosystems, Inc.
RPID

NASDAQ > Medical - Devices
DCF:$0.01  |   P/E: -
$0.06(6.68%)
Change
Rating:
Price: $0.9 USD
Market Cap: $41.32M

...Loading RPID Peers...





Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

    193 Employees

    CEO : Mr. Robert G. Spignesi Jr.

    Address : 1001 Pawtucket Boulevard West, Lowell,MA, US, - 01854,

Key ExcutivesDesignation
Mr. Michael Beaulieu C.F.A.Vice President of Investor Relations & Corporate Communications
Mr. John J. Addington WilsonChief Operating Officer
Mr. Michael WysockiSenior Vice President of Sales & Marketing
Mr. Robert G. Spignesi Jr.Chief Executive Officer, President & Director
James XuVice President of Legal & Secretary
Ms. Kristine WilliamsSenior Vice President of Product
Mr. Sean M. Wirtjes CPAChief Financial Officer